Skip to main content

Table 1 Demographics and clinical characteristics of patients with Kawasaki disease shock syndrome and Kawasaki disease (continuous variables were described as median and range)

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS (n=13) KD (n=91) P value
Age, (years) 5.1 (0.5–10.6) 2.3 (0.2–8.4) 0.000
Male (%) 46.2% (6/13) 58.2% (53/91) 0.411
Fever duration (days) 11 (8–23) 8 (3–29) 0.002
Total hospital day (days) 18 (6–31) 6 (3–18) 0.000
Follow up duration (months) 10 (1–105) 13 (0–175) 0.723
ICU care (%) 53.8% (7/13) 0.0% (0/91) 0.000
ICU care duration (days) 4 (0–11) 0 0.000
Inotropic drugs (%) 92.3% (12/13)§ 1.1% (1/91) 0.000
Respiratory support
 - No support 30.8% (4/13) 100% (91/91) 0.000
 - Oxygen delivery 53.8% (7/13) 0.0% (0/91) 0.000
 - Mechanical ventilation 15.4% (2/13) 0.0% (0/91) 0.015
Mortality (%) 0.0% (0/13) 0.0% (0/91)  
  1. KDSS Kawasaki disease shock syndrome, KD Kawasaki disease, SS Septic shock and toxic shock syndrome, ICU Intensive care unit